(4S,4'S)-2,2'-(4,6-二苯并呋喃二基)双[4,5-二氢-4-苯基恶唑], (4S,4'S)-2,2'-(4,6-Dibenzofurandiyl)bis[4,5-dihydro-4-phenyloxazole]

(R)-VANOL膦酸酯, (6aR)-14-Hydroxy-6,7-diphenyl-14-oxide-dinaphtho[1,2-d:2',1'-f][1,3,2]dioxaphosphepin

(11bR)-4-羟基-9,14-二硝基-2,6-双[2,4,6-三(1-甲基乙基)苯基]-4-氧化物-二萘酚[2,1-d:1',2'-f][1,3,2]二氧磷, (11bR)-4-Hydroxy-9,14-dinitro-2,6-bis[2,4,6-tris(1-methylethyl)phenyl]-4-oxide-Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin

(11bS)-2,6-双[4-(9-蒽基)-2,6-双(异丙基)苯基]-4-羟基-4-氧化物-二萘酚[2,1-d:1',2'-f][1,3,2]二氧磷, (11bS)-2,6-Bis[4-(9-anthracenyl)-2,6-bis(isopropyl)phenyl]-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin

(3aR,8aR)-4,4,8,8-四(3,5-二叔丁基苯基)-6-羟基-2,2-双(4-(三氟甲基)苯基)四氢-6-氧化物-[1,3]二氧并[4,5-e][1,3,2]二氧磷, (3aR,8aR)-4,4,8,8-Tetrakis(3,5-di-tert-butylphenyl)-6-hydroxy-2,2-bis(4-(trifluoromethyl)phenyl)tetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine

(3aR,8aR)-四氢-6-羟基-2,2-二甲基-4,4,8,8-四(3,5-二叔丁基苯基)-6-氧化物-[1,3]二氧并[4,5-e][1,3,2]二氧磷, (3aR,8aR)-Tetrahydro-6-hydroxy-2,2-dimethyl-4,4,8,8-tetrakis(3,5-di-tert-butylphenyl)-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine

(3aS,8aS)-四氢-6-羟基-2,2-二甲基-4,4,8,8-四(4-(叔丁基)苯基)-6-氧化物-[1,3]二氧并[4,5-e][1,3,2]二氧磷, (3aS,8aS)-Tetrahydro-6-hydroxy-2,2-dimethyl-4,4,8,8-tetrakis(4-(tert-butyl)phenyl)-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine

(11aS)-3,7-双((4-(1,1-二甲基乙基)苯基)-10,11,12,13-四氢-10,10,13,13-四甲基-5-羟基-二茚基[7 ,1-de:1',7'-fg] [1,3,2]二氧杂磷霉素, (11aS)-3,7-Bis((4-(1,1-dimethylethyl)phenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin

(3-(Tert-butoxy)-2',6'-diisopropyl-6-methoxy-[1,1'-biphenyl]-2-yl)dicyclohexylphosphane GPhos

CALLERY? Methoxydiethylborane